CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total Revenues	$ 566,210	$ 165,158
Costs and Expenses
Costs of revenue	532,890	72,782
Research, development and manufacturing operations	1,406,322	728,036
Selling, general and administrative	821,266	561,709
Depreciation and amortization	16,665	12,872
Total Costs and Expenses	2,777,143	1,375,399
Loss from Operations	(2,210,933)	(1,210,241)
Other Income/(Expense)
Other income/(expense), net		800
Interest expense	(2,086,314)	(562,079)
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net		3,617,904
Total Other Income/(Expense)	(2,086,314)	3,056,625
Income/(Loss) on Equity Method Investments	(2)
Net Income/(Loss)	$ (4,297,249)	$ 1,846,384
Net Income/(Loss) Per Share (Basic)	$ (0.20)	$ 0.51
Net Income/(Loss) Per Share (Diluted)	$ (0.20)	$ 0.05
Weighted Average Common Shares Outstanding (Basic)	21,671,248	3,633,730
Weighted Average Common Shares Outstanding (Diluted)	21,671,248	32,511,508
Other Comprehensive Income/(Loss)
Foreign currency translation gain/(loss)	$ (7,097)
Net Comprehensive Income/(Loss)	(4,304,346)	$ 1,846,384
Products
Total Revenues	54,210	$ 165,158
Milestone and engineering
Total Revenues	$ 512,000